Zhifang Yao

First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial

Lin Shen, Yanqiao Zhang, Ziyu Li et al. · Nature Medicine · 2025 · 59 citations

Esophageal Cancer, Gastrointestinal Oncology, Medicine +8

Efficient extraction of flavonoids from Polygonatum sibiricum using a deep eutectic solvent as a green extraction solvent

Hongli Zhang, Hao Fei-long, Zhifang Yao et al. · Microchemical Journal · 2022 · 50 citations

Solvent Extraction, Polyphenolics, Botany +9

Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial

Xiangyu Gao, Ke Ji, Yongning Jia et al. · Nature Medicine · 2024 · 38 citations

Esophageal Cancer, Gastrointestinal Oncology, Medicine +9

A phase Ib/II, multicenter, open-label study of AK104, a PD-1/CTLA-4 bispecific antibody, combined with chemotherapy (chemo) as first-line therapy for advanced gastric (G) or gastroesophageal junction (GEJ) cancer.

Jiafu Ji, Lin Shen, Xiangyu Gao et al. · Journal of Clinical Oncology · 2022 · 19 citations

Esophageal Cancer, Immunology, Gastroenterology +21

A phase Ib/II, multicenter, open-label study of AK104, a PD-1/CTLA-4 bispecific antibody, combined with chemotherapy (chemo) as first-line therapy for advanced gastric (G) or gastroesophageal junction (GEJ) cancer: 2-Year update data.

Jiafu Ji, Lin Shen, Ziyu Li et al. · Journal of Clinical Oncology · 2023 · 16 citations